Your browser doesn't support javascript.
loading
Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
Daubert, Jean-Claude; Martins, Raphaël; Leclercq, Christophe.
Afiliação
  • Daubert JC; University of Rennes, Rennes 35000, France. Electronic address: jcdaubert@orange.fr.
  • Martins R; University of Rennes, Rennes 35000, France.
  • Leclercq C; University of Rennes, Rennes 35000, France.
Heart Fail Clin ; 13(1): 153-164, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27886920
ABSTRACT
Both cardiac resynchronization therapy with a pacemaker (CRT-P) and with a biventricular implantable cardioverter-defibrillator (CRT-D) are electrical treatment modalities validated for the management of chronic heart failure. There is no strong scientific evidence that a CRT-D must be offered to all candidates. Common sense should limit the prescription of these costly and complicated devices. The choice of CRT-P is currently acceptable. A direction to explore could be to downgrade from CRT-D to CRT-P at the time of battery depletion in patients with large reverse remodeling and no ventricular tachycardia and ventricular fibrillation detected.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Heart Fail Clin Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Heart Fail Clin Ano de publicação: 2017 Tipo de documento: Article